Armistice Capital’s Pfizer PFE Stock Holding History

Armistice Capital’s Portfolio PFE Stock Details PFE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-211,740	Closed	-$5.37M	–	254
2025 Q1	$5.37M	Buy	+211,740	New	+$5.54M	0.08%	110
2023 Q3	–	Sell	-2,096,000	Closed	-$76.9M	–	273
2023 Q2	$76.9M	Buy	+2,096,000	New	+$81.6M	1.11%	12
2022 Q4	–	Sell	-536,000	Closed	-$23.5M	–	227
2022 Q3	$23.5M	Buy	536,000 +80,000	+18%	+$3.89M	0.41%	52
2022 Q2	$23.9K	Buy	+456,000	New	+$23.2M	0.42%	54
2021 Q4	–	Sell	-250,000	Closed	-$10.8M	–	167
2021 Q3	$10.8M	Sell	250,000 -774,000	-76%	-$34.3M	0.18%	88
2021 Q2	$40.1M	Sell	1,024,000 -176,000	-15%	-$6.84M	0.72%	39
2021 Q1	$43.5M	Buy	+1,200,000	New	+$42.6M	1%	32
2020 Q2	–	Sell	-714,612	Closed	-$22.1M	–	91
2020 Q1	$22.1M	Buy	+714,612	New	+$24.3M	1.37%	30

Other funds holding PFE

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

State Farm Mutual Automobile Insurance Bloomington, Illinois $127B AUM 32.55% 1-Year Est. Return

Armistice Capital's PFE Position: Q2 2025 in Review

Armistice Capital sold out of Pfizer (PFE) in Q2 2025, closing a stake of 211,740 shares — an estimated $5.37M sold.

Armistice Capital first reported a position in PFE in Q1 2020 and held it in 8 quarters. The position peaked at $76.9M in Q2 2023. 2,809 funds tracked by Wall St. Rank hold PFE as of Q2 2025.

Armistice Capital reported no remaining Pfizer position as of Q2 2025 after selling out during the quarter.
Armistice Capital sold 211,740 Pfizer shares in Q2 2025, an estimated $5.37M.
Armistice Capital first reported a position in Pfizer in Q1 2020 and held it in 8 quarters.
Armistice Capital's Pfizer position peaked at $76.9M in Q2 2023.
2,809 funds tracked by Wall St. Rank held Pfizer as of Q2 2025.

Based on Armistice Capital's 13F filing for Q2 2025, filed 14 Aug 2025.